ReginaIreneJakackiMD

Clinical Trials

• Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors Start of enrollment: 1998 Mar 01

  Completed

  Phase 2

• Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma Start of enrollment: 2000 Nov 01

  Completed

  Phase 1

• Lobradimil and Carboplatin in Treating Children With Brain Tumors Start of enrollment: 1998 Mar 01

  Completed

  Phase 2

• Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors Start of enrollment: 2004 Feb 01

  Completed

  Phase 1

• Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas Start of enrollment: 2005 Mar 21

  Completed

  Phase 2

• Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma Start of enrollment: 2006 Jun 01

  Completed

  Phase 1

• Study of PEG-Intron for Plexiform Neurofibromas Start of enrollment: 2006 Dec 01

  Completed

  Phase 2

• Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma Start of enrollment: 2010 Apr 19

  Active, not recruiting

  Phase 1, Phase 2

• A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction With Poly-ICLC in Pediatric Gliomas Start of enrollment: 2009 Feb 01

  Active, not recruiting

  Phase 1

• Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor Start of enrollment: 2011 Aug 01

  Completed

  Phase 2

• A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB) Start of enrollment: 2013 May 06

  Completed

  Phase 2

• Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors Start of enrollment: 2012 Nov 14

  Completed

  Phase 1

• MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma Start of enrollment: 2013 Nov 01

  Completed

  Phase 1

• Peginterferon Alfa-2b in Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery Start of enrollment: 2014 Apr 01

  Terminated

  Phase 2

• Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors Start of enrollment: 2014 Mar 28

  Completed

  Phase 1, Phase 2

• Join now to see all